Skip to main content
Equibles
TYRA logo

TYRA · Tyra Biosciences, Inc.

Track TYRA — free

Use TYRA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$28.65 +3.79 (+15.25%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$1.71B
Shares
59.68M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

TYRA Latest Reported Short Interest

FINRA reported 9,689,392 TYRA shares sold short as of the August 14, 2026 settlement date, an increase of 442,457 shares. Days to cover was 12.65 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

TYRA Short Interest Forecast

Equibles' model estimates 9,648,675 shares sold short for the August 31, 2026 settlement, -0.4% versus the latest reported position, with a likely range of 8,959,686 to 10,337,192 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 31 Low confidence 60% chance it falls
9,648,675 -0.4% vs reported
Likely range 8,959,686 to 10,337,192 The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
79/100
Short interest 16.2% of shares — P96 Days to cover 12.7 — P93 Price vs VWAP -0.8% — P48 Short-volume trend +4.5% — P68 Short interest change +4.8% — P68 Worst FTD 0.04% of shares — P73

Positioning score 78.9 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-08-14). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-09-06 10:01 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 9,689,392 9,246,935 +442,457 12.65
    2026-07-31 9,246,935 9,930,770 -683,835 17.83
    2026-07-15 9,930,770 11,924,900 -1,994,130 15.50
    2026-06-30 11,924,900 9,866,801 +2,058,099 9.37
    2026-06-15 9,866,801 9,281,430 +585,371 9.20
    2026-05-29 9,281,430 8,065,431 +1,215,999 13.12
    2026-05-15 8,065,431 7,708,671 +356,760 12.65
    2026-04-30 7,708,671 7,709,241 -570 6.68
    2026-04-15 7,709,241 8,264,887 -555,646 7.61
    2026-03-31 8,264,887 6,853,153 +1,411,734 7.94
    2026-03-13 6,853,153 5,667,913 +1,185,240 4.14
    2026-02-27 5,667,913 5,144,732 +523,181 7.51
    2026-02-13 5,144,732 5,013,172 +131,560 6.84
    2026-01-30 5,013,172 5,073,265 -60,093 6.54
    2026-01-15 5,073,265 5,791,320 -718,055 8.33
    2025-12-31 5,791,320 4,238,532 +1,552,788 10.65
    2025-12-15 4,238,532 4,146,608 +91,924 9.09
    2025-11-28 4,146,608 4,375,041 -228,433 5.75
    2025-11-14 4,375,041 4,706,779 -331,738 18.41
    2025-10-31 4,706,779 5,782,614 -1,075,835 16.51
    2025-10-15 5,782,614 5,915,988 -133,374 33.19
    2025-09-30 5,915,988 5,952,493 -36,505 33.07
    2025-09-15 5,952,493 5,919,802 +32,691 26.23

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1863127 CUSIP 90240B106 13F (30d) 134 filings 134 filers Visit website Investor relations